Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Celli
    Junior Member
    • Feb 2011
    • 2

    Underdispersed mapped RNA-Seq reads

    Hello all,

    I am working on analyzing RNA-Seq samples for differential expression and am perplexed by the distribution of my data, which appears to be under- rather than overdispersed relative to a Poisson distribution.

    For background:
    1. I created a preliminary de Novo assembly of my RNA-Seq transcripts using CLC workbench (reads were first trimmed, etc, reads were high quality and looked good using diagnostics in FastQC).
    2. I mapped my reads to the de Novo assembly using the RNA-Seq mapping function in CLC workbench.
    3. I imported my mapped read counts into R, to analyze the differential expression using edgeR

    In edgeR, my common dispersion parameter is ~2.5. I checked the MA Plots and noticed how 'odd' my data distributions appeared. The attached plot is an example of a comparison between lanes using an MA plot (all between lane comparisons look similar regardless of experiment group).

    Histograms similarly confirm that aside from 'zeros', my most about count data (by lane) is in the thousands of reads per de Novo contig.

    My questions are as follows:
    1. Have others encountered similar data distributions?
    2. If so, are there any programs to analyze underdispersed (or whatever this is) data? DEGseq seems like it may be 'closer' as it assumes a Poisson distribution, but this still isn't the correct distribution. I've also been reading about using GLM for generalized Poisson distributions.
    3. Could this all be caused by a suboptimal de Novo assembly? Or by RNA degradation prior to sequencing?

    Any thoughts would be greatly appreciated! I am currently working to generate a 'best' assembly using multiple kmer lengths in Oases-Velvet, and to annotate some of the very abundant contigs for biological relevance. Any other suggestions regarding issues related to contamination, assembly,etc?

    Thanks so much from a beginner!!
    Celli
    Attached Files
  • Simon Anders
    Senior Member
    • Feb 2010
    • 995

    #2
    It's quite sure that this underdispersion is not genuine but rather a signal that something went severely wrong. Please give a few more details on your design (what are you comparing? how many replicates?) and your analysis steps.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      Yesterday, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:10 AM
    0 responses
    8 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    39 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Working...